Publications en collaboration avec des chercheurs de Hospital Clínico San Carlos de Madrid (30)

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

2021

  1. Fewer COVID-19-associated strokes and reduced severity during the second COVID-19 wave: The Madrid Stroke Network

    European Journal of Neurology, Vol. 28, Núm. 12, pp. 4078-4089

  2. Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab

    Frontiers in Immunology, Vol. 12

  3. Stroke Acute Management and Outcomes During the COVID-19 Outbreak: A Cohort Study From the Madrid Stroke Network

    Stroke, Vol. 52, Núm. 2, pp. 552-562

  4. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2020

  1. Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations

    Neurologia, Vol. 35, Núm. 4, pp. 258-263

  2. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case–control study

    European Journal of Neurology, Vol. 27, Núm. 9, pp. 1738-1741

  3. Impact of the COVID-19 pandemic on the organisation of stroke care. Madrid Stroke Care Plan

    Neurologia, Vol. 35, Núm. 6, pp. 363-371

2019

  1. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    Neurologia, Vol. 33, Núm. 7, pp. 419-426

2017

  1. The Direct Referral to Endovascular Center criteria: a proposal for pre-hospital evaluation of acute stroke in the Madrid Stroke Network

    European Journal of Neurology, Vol. 24, Núm. 3, pp. 509-515

2016

  1. Réplica a la carta «Algunas consideraciones sobre el infarto cerebral desde otra óptica»

    Neurologia

2014

  1. Análisis de recursos asistenciales para el ictus en España en 2012: ¿beneficios de la Estrategia del Ictus del Sistema Nacional de Salud?

    Neurologia, Vol. 29, Núm. 7, pp. 387-396

  2. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  3. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

2013

  1. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603

2012

  1. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?

    International Journal of Stroke, Vol. 7, Núm. 1, pp. 7-13

  2. Diabetes and previous stroke: Hazards for intravenous thrombolysis?

    European Journal of Neurology, Vol. 19, Núm. 4, pp. 587-593

  3. Efficacy of intravenous thrombolysis according to stroke subtypes: The Madrid Stroke Network data

    European Journal of Neurology, Vol. 19, Núm. 12, pp. 1568-1574